Search results
Moderna's (MRNA) Next-Gen COVID-19 Jab Study Meets Efficacy Goal
Zacks via Yahoo Finance· 7 days agoData from a late-stage study shows that Moderna's (MRNA) next-generation COVID-19 vaccine achieved...
COVID vaccine companies told to focus on KP.2 variant for fall shots, per FDA announcement
Fox News· 7 days agoThe U.S. Food and Drug Administration (FDA) has recommended that COVID vaccine manufacturers update...
We Won't Solve Long COVID Until We Decide What It Is
Medscape· 4 days agoIs a slow recovery from COVID-19 the lingering effects of a bad infection or the start of a new syndrome?
FDA recommends COVID jab manufacturers update formulas to combat new strain
BizPac Review· 6 days agoA new strain of COVID has prompted recommendations for vaccine companies to update their formulas in anticipation of cases in the fall. The U.S. Food and Drug Administration (FDA) announced ...
Why 93% Of This Biotech's Value Just Went Up In Smoke
Investor's Business Daily· 4 days agoWedbush analyst Laura Chico slashed her price target on Aerovate stock to 3 from 41, calling the...
Texas Biomed expanding animal research complex with $20 million building
San Antonio Express-News· 2 days agoThe Texas Biomedical Research Institute is continuing expansion of a new animal research complex on...
Moderna's (MRNA) Next-Gen COVID-19 Jab Study Meets Efficacy Goal
Zacks· 7 days agoData from a late-stage study shows that Moderna's (MRNA) next-generation COVID-19 vaccine achieved non-inferior vaccine efficacy against COVID-19 when compared with its previously approved bivalent COVID-19 vaccine.
Why Quantum Shares Are Trading Lower By 45%? Here Are Other Stocks Moving In Tuesday's Mid-Day...
Benzinga· 3 days agoShares of Quantum Corporation QMCO fell sharply during Tuesday's session after the company reported...
COVID vaccine companies told to focus on KP.2 variant for fall shots, per FDA announcement
AOL· 7 days agoThe U.S. Food and Drug Administration (FDA) has recommended that COVID vaccine manufacturers update their formulas for fall doses, in an attempt to target the KP.2 strain of the JN.1 variant ...